{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-037141","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.385809+00:00","generated_at":"2026-06-12T14:35:50.858261+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Graphite Bio appoints Kimberlee Drapkin as independent director","bullets":["Board expanded from 10 to 11; Drapkin appointed effective July 28, 2023.","Drapkin has 25+ years biotech/pharma experience; formerly CFO at Jounce Therapeutics.","She will receive cash and equity under Director Compensation Policy, prorated from appointment.","No arrangements or family relationships with other directors or executive officers.","She serves on boards of Acumen Pharmaceuticals, Imugene, and Kineta."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-037141","json":"https://secwatch.observer/filing/0000950170-23-037141.json","markdown":"https://secwatch.observer/filing/0000950170-23-037141.md","text":"https://secwatch.observer/filing/0000950170-23-037141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/0000950170-23-037141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/grph-20230728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T14:35:50.858261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ea695b096","claim":"Kimberlee C. Drapkin was appointed as director at LENZ Therapeutics, Inc..","evidence_excerpt":"On July 28, 2023, the Board of Directors (the “Board”) of Graphite Bio, Inc. (the “Company”) increased the size of the Board from ten to eleven members and appointed Kimberlee C. Drapkin as a director of the Company, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815776/000095017023037141/0000950170-23-037141-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}